TGFB1 and cancer: Tumor secretions, when compared to secretions from adjacent non-cancerous endometrium, contained significantly higher levels of TGFβ, an immunosuppressive mediator, that we have previously shown directly suppresses CD8+T cell cytotoxicity of both pre- and post-menopausal endometrial CD8+T cells from women without cancer (17).